American chemical society - 238th national meeting & exposition. Novel small molecule therapeutics

Research output: Contribution to journalArticle


The Novel Small Molecule Therapeutics session of the American Chemical Society 238th National Meeting and Exposition, held in Washington DC, included topics covering new therapeutic developments in CNS, anti-infective, cardiovascular and anti-inflammatory applications. This conference report highlights selected presentations on PAR2 (protease-activated receptor 2) antagonists, adenosine and P2Y receptor agonists and antagonists, antimicrobials and neuroprotective compounds.

Original languageEnglish
Pages (from-to)612-613
Number of pages2
Issue number10
StatePublished - 1 Oct 2009


Cite this